The lung allocation score (LAS) system has been implemented to reduce waiting list time and mortality in the USA, but it remains uncertain how the LAS would reflect the impairment in health-related quality of life (HRQOL), which is another lung transplantation treatment goal to be improved in addition to survival. We thus investigated the relationships of the LAS with mortality and HRQOL in Japanese lung transplantation candidates.
INTRODUCTION
Since the lung allocation score (LAS) system was implemented in the USA in 2005, it has met its primary goals of reducing waiting list time and mortality and of prioritizing patients based on urgency [1] . Despite several unresolved issues, the LAS system has also been adopted by Eurotransplant [2] . Owing to its close association with mortality, the LAS has recently been used as a measure of disease severity for patients on the transplant waiting list [3] . However, despite the striking improvement in the 5-year survival rate after lung transplantation, for patients the importance of health-related quality of life (HRQOL) may outweigh that of survival rates [4] . Improving patients' symptoms and health is an important goal of lung transplantation [5, 6] . These measurements are not directly used in the LAS calculation, and it remains uncertain how the LAS reflects the impairment in patient-reported outcomes such as HRQOL.
The selection of lung transplantation recipients in Japan currently occurs on a 'first come, first served' basis, after taking into account blood type compatibility, distance from the donor hospital and size matching based on the predicted vital capacity. To date, more than 400 lung transplantations have been performed in Japan, and discussion has been raised regarding the fact that waiting list mortality varies depending on the original disease. In this situation, the need for a new lung allocation system, such as the LAS system, has recently been discussed nationwide as a means to more fairly allocate the inadequate number of donor lungs.
Because the LAS system is based on multidimensional analyses and HRQOL is considered to represent the overall effects of diseases on individuals, we hypothesized that the symptoms of impairment and health of lung transplantation candidates would be reflected in the score. Recently developed multidimensional disease severity indices in respiratory diseases are well correlated with HRQOL [7, 8] . Therefore, in this study into the use of the LAS system, we aimed (i) to confirm the ability of the LAS to predict mortality; and (ii) to investigate the relationship between the LAS and HRQOL in Japanese lung transplantation candidates.
PATIENTS AND METHODS

Subjects
One hundred and two candidates for lung transplantation at Kyoto University Hospital between May 2009 and August 2013 were consecutively recruited to participate in this study. Subjects were included if they (i) were newly registered lung transplantation candidates; (ii) were aged over 15 years and (iii) had no uncontrolled comorbidities, such as malignant, cardiac or cerebrovascular diseases. Exclusion criteria were: (i) patients needing a heart-lung transplantation and (ii) refusal to participate in the study. Patientreported measures and physiological measures were assessed at entry. The Ethical Committee of Kyoto University approved the study protocol (E-1429). We obtained written informed consent from all patients. The follow-up of the patients was determined in March 2014.
Lung allocation score
The LAS of each patient was calculated using the LAS calculator on the Organ Procurement and Transplantation Network (OPTN) website (http://optn.transplant.hrsa.gov/resources/professionalResources.asp? index=88) in September 2013. Since the LAS may change on a daily basis because of age, the LAS in this study was modified to be as it was when the patient completed the self-administered questionnaires.
Patient-reported outcomes
Assessment of patient-reported outcomes included HRQOL, dyspnoea and psychological status. HRQOL was assessed using the Japanese versions of the generic questionnaire, the Medical Outcomes Study 36-item short form (SF-36) [9, 10] and the St George's Respiratory Questionnaire (SGRQ) [11, 12] . The SF-36 contains 36 items that are aggregated into 8 subscales, including physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional and mental health. The scores for each parameter range from 0 to 100; with a higher score generally indicating a patient who feels well. The SGRQ consists of 50 items divided into symptoms, activities and impacts. Scores range from 0 to 100. Lower SGRQ scores indicate less impairment.
Dyspnoea was evaluated using the Japanese version of the modified Medical Research Council (mMRC) dyspnoea scale [13] . This is a 5-point scale ranging from 0 to 4 based on the degree of physical activity that precipitates dyspnoea. Higher scores indicate more severe dyspnoea. Psychological status was evaluated using the Japanese version of the hospital anxiety and depression scale [13, 14] . This scale consists of 14 items, 7 for anxiety and 7 for depression. Each item is scored from 0 to 3, where a score of 3 corresponds to the highest level of anxiety or depression. The sum of these items produces two subscales ranging from 0 to 21.
Physiological outcomes
Pulmonary function tests were performed using a Minato System 21 spirometer (Minato Medical Science Co Ltd, Osaka, Japan) to measure the forced vital capacity (FVC) and the forced expiratory volume in 1 s (FEV 1 ). A 6-min walking test was performed based on the guideline [15] , and the distance covered was recorded as the 6-min walking distance (6MWD).
Statistical analysis
Statistical analysis was performed using the StatView (version 4.5) software package (Abacus Concepts, Berkeley, CA, USA). The results are presented as median [interquartile range (IQR), unless otherwise stated. For the survival analysis, patients who underwent lung transplantation or were excluded from the waiting lists were censored, and the duration from the study entry to death, the transplant date, and the last excluded date or last survival date were recorded. Cox proportional hazard analyses were performed to investigate the relationships between the LAS and physiological measurements and mortality. Results of the regression analysis were presented in terms of the estimated relative risks (RRs) with corresponding 95% confidence intervals (CIs). The log-rank test was used to analyse the relationship between disease severity based on the median of the LAS and mortality. Spearman's rank correlation tests were used to examine the relationships between HRQOL scores and clinical measurements. To analyse the relative relationship between the LAS and HRQOL, multivariate analyses were performed using the SGRQ total score as a dependent variable and the LAS and other measurements as independent variables. Values of P < 0.05 were considered statistically significant.
RESULTS
Patient characteristics
One hundred and two patients were approved as appropriate candidates for lung transplantation by the institutional review board of Kyoto University Hospital. The study included 47 female patients and 55 male patients, with a median age of 46 years (IQR: 31-54 years; Table 1 ). One patient did not perform a pulmonary function test because of pneumothorax, and 7 patients did not 
Longitudinal survival study
During a mean follow-up period of 11.6 months (range: 1-40 months), 22 patients died due to progression of their original disease. Of the 102 patients, 24 and 19 underwent deceased-and living-donor lung transplantations, respectively. One patient was excluded from the waiting list owing to occurrence of lung cancer.
On Cox proportional hazard analysis, the LAS was significantly related to mortality (RR = 1.13, 95% CI = 1.04-1.22, P = 0.0026), while physiological measurements of age, FEV 1 (%predicted), FVC (%predicted) and 6MWD were not significantly related (RR = 1.03, 95% CI = 0.99-1.06, P = 0.15; RR = 1.01, 95% CI = 0.99-1.04, P = 0.25; RR = 0.99, 95% CI = 0.96-1.01, P = 0.23 and RR = 1.00, 95% CI = 1.00-1.00, P = 0.87, respectively). Fig. 2 shows the Kaplan-Meier survival curve based on the median value of the LAS distribution. A significant difference was found in the survival between the two groups according to the LAS distribution (P = 0.0016).
Relationships between the lung allocation score, physiological measurements and health-related quality of life Baseline HRQOL data are presented in Table 2 . Relationships between the LAS, physiological measurements and HRQOL are presented in Table 3 . The LAS was significantly related to four of eight subscales ( physical functioning, role-physical, social functioning and role-emotional) of the SF-36 (Spearman's correlation coefficient (Rs) = −0.26, −0.29, −0.27 and −0.24, P < 0.05, respectively) and activities, impacts and total SGRQ scores (Rs = 0.31, 0.24 and 0.21, P < 0.05, respectively). FEV 1 , FVC and 6MWD were significantly related to three, three and four subscales of the SF-36, respectively (Rs = 0.21-0.54, P < 0.05). Regarding the SGRQ, FEV 1 was significantly related to three components and the total score (Rs = −0.42 to −0.28, P < 0.05), and FVC and 6MWD were significantly related to the activities, impacts and total scores (Rs = −0.40 to −0.26, P < 0.05).
Relationships between dyspnoea, psychological status and health-related quality of life
Baseline mMRC and HADS data are presented in Table 2 . Relationships between dyspnoea, psychological status and HRQOL are presented in Table 4 . The mMRC was significantly related to all eight subscales of the SF-36 (Rs = −0.56 to −0.22, P < 0.05) and the three components and total score of the SGRQ (Rs = 0.65-0.67, P < 0.05). Anxiety and depression scales of the HADS were also significantly related to all eight SF-36 subscales (Rs = −0.77 to −0.39 and −0.61 to −0.28, P < 0.05, respectively) and three components and the total score of the SGRQ (Rs = 0.37-0.71 and 0.25-0.67, P < 0.05, respectively).
Multivariate analyses of the ability of the lung allocation score to predict health-related quality of life
We next examined the relative relationship between the LAS and HRQOL when compared with regard to dyspnoea and psychological status ( Table 5 ). The SGRQ total score was used as a measurement of HRQOL. As the HADS anxiety and depression scales strongly correlate with each other (Rs = 0.78, P < 0.001), the anxiety scale was used in these analyses. In multivariate models I and II, mMRC and the anxiety scale of the HADS were significantly related to the SGRQ (P < 0.001), but the LAS was not (coefficient of determinations (R 2 ) = 0.41 and 0.44 in each model). When mMRC, HADS anxiety scale and LAS were entered simultaneously into multivariate model III, mMRC and HADS anxiety scale were both significantly related to the SGRQ (P < 0.001), but the LAS was not (P = 0.21) (R 2 = 0.57).
DISCUSSION
We found that the LAS predicted mortality in lung transplantation candidates in Japan. Although the LAS was also significantly related to some HRQOL scores, their correlation coefficients were similar to those between other physiological measurements and HRQOL. In contrast, dyspnoea and psychological status were more significantly related to HRQOL than the LAS. The LAS weighs both urgency of need and expected posttransplant survival to calculate an allocation score based on underlying disease subgroups and multiple other variables, thereby decreasing waiting list mortality. We demonstrated that the LAS had excellent discriminative and predictive properties in Japan, as seen from the frequency distributions and significant relations to mortality. Therefore, it is possible that a system similar to the LAS would also work well in Japan.
The LAS was significantly related to four of eight subscales of the SF-36 and two components and the total scores of the SGRQ, indicating that the LAS reflects the HRQOL of lung transplant candidates. However, their correlation coefficients were relatively low, with the highest at 0.31. Thus, the LAS would classify disease severity differently to the HRQOL. While the clinical aim of lung transplantation is to improve both survival and HRQOL, 'transplant success' in research is currently defined by patient or allograft survival alone. Unfortunately, in the USA, no study of HRQOL has been reported since the LAS system was implemented [5] . Therefore, HRQOL should be evaluated separately from the LAS, and future research and organ allocation policies should seek to incorporate HRQOL to more comprehensively capture the 'net benefit' of lung transplantation [6] . The recent development of a novel lung transplant-specific disability questionnaire is an attempt to incorporate such patient-reported outcomes into the clinical goals of lung transplantation [16] . Recently, respiratory disorders have been shown to have both local and systemic effects [17] . As it is impossible to capture the overall impact of the disease by pulmonary function testing alone, multidimensional analysis has been introduced. In chronic obstructive pulmonary disease, the body mass index, dyspnoea, exercise capacity and airflow limitation index [18] have led the field, and 15 indices have since been developed [19] . Numerous multidimensional disease severity indices have been developed for other respiratory disorders such as idiopathic pulmonary fibrosis [20] , bronchiectasis [8] and pulmonary arterial hypertension [21] . These indices have been validated in their close correlation to mortality and disease exacerbations. The LAS can be considered to represent multidimensional severity among severe heterogeneous respiratory diseases requiring lung transplantation. These results were verified from the present results showing that the LAS alone was significantly related to mortality among physiologic measurements.
Multidimensional disease severity indices tend to be significantly related to HRQOL [7, 8] rather than pulmonary function [7] . These significant relationships are usually driven by dyspnoea, which is a composite factor in most multidimensional indices [18] [19] [20] [21] . However, this study showed that the relationship between the LAS and HRQOL was as weak as that of pulmonary function, which may be because the LAS does not measure dyspnoea or psychological factors, which are important determinants of HRQOL [22, 23] . This explanation is consistent with the present results showing that the correlation coefficients between HRQOL and mMRC and HADS tended to be higher than those between HRQOL and LAS (Tables 3 and 4) . In multivariate analyses of the SGRQ total score prediction, the LAS did not significantly add to dyspnoea or psychological status. Presently, the introduction of the LAS in lung transplantation has been successful, and continues to be improved. These patientreported outcomes might be dimensions that are considered for inclusion or assessment in addition to the LAS with regard to mortality and HRQOL.
Limitations of the present study include the fact that we only evaluated the LAS in a Japanese population. Furthermore, we calculated the individual LAS using the website option, the LAS calculator. This option is provided by the OPTN website, but the actual LAS provided to a candidate is calculated by UNet SM based solely on the data that are entered by the transplant centre.
In conclusion, we demonstrated the possible effectiveness of using the LAS system for its discriminative and predictive features in Japan. The severity assessment in lung transplant candidates should be more focused on the patients' health and symptoms, as improvement in the HRQOL is now an important clinical goal.
